Effect of Low-Dose Aspirin on the Elderly

Area of Science:

• Cardiology
• Oncology
• Geriatrics

Background:

• Aspirin is a widely used antiplatelet medication for cardiovascular event and stroke prevention.
• High-dose aspirin (500 mg daily) may reduce long-term colorectal cancer risk, but adverse effects can limit its effectiveness.
• Individuals with diabetes mellitus have an elevated risk of cardiovascular events, creating uncertainty about aspirin's role in this population.

Purpose of the Study:

• To evaluate the effects and risks of low-dose aspirin use in elderly individuals.
• To assess the balance between aspirin's benefits (cardiovascular event prevention) and risks (bleeding) in specific populations.
• To review the current understanding of aspirin's impact on colorectal cancer and cardiovascular health.

Main Methods:

• Literature review of studies on aspirin dosage, cardiovascular events, stroke prevention, colorectal cancer, and bleeding risk.
• Analysis of research assessing aspirin's efficacy and safety in elderly populations and individuals with diabetes mellitus.
• Evaluation of the relationship between aspirin use, incidence, and mortality in colorectal cancer patients.

Main Results:

• Low-dose aspirin is established for cardiovascular event and stroke prevention.
• While high-dose aspirin may reduce colorectal cancer risk, its long-term use is constrained by adverse effects.
• Aspirin use lowers occlusive vascular event risk but increases bleeding risk, particularly with continuous use in older adults.

Conclusions:

• The benefits of low-dose aspirin for cardiovascular protection in the elderly require careful risk-benefit assessment.
• Uncertainty remains regarding optimal aspirin use for cardiovascular prevention in individuals with diabetes.
• Reducing inappropriate aspirin usage, especially among the elderly, is crucial due to increased bleeding risks with prolonged use.